< Back to previous page
Researcher
Samal Bissenova
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 2018 → Today
Projects
1 - 1 of 1
- Neutrophils and post-translationally modified beta-cell proteins: a driving force behind type 1 diabetes?From1 Oct 2018 → 13 Nov 2023Funding: FWO fellowships
Publications
1 - 8 of 8
- Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.(2023)
Authors: Samal Bissenova, Lut Overbergh
Pages: 183 - 196 - Neutrophils: a driving force in type 1 diabetes?(2023)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
- A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes(2023)
Authors: Gabriele Sassi, Amber Wouters, Pierre Lemaitre, Samal Bissenova, Conny Gysemans
- High-Throughput Analysis of Neutrophil Extracellular Trap Le of People with Type 1 Diabetes(2023)
Authors: Samal Bissenova, Markus Bösch, Hannelie Korf, Kristina Casteels, An Teunkens, Chantal Mathieu, Conny Gysemans
- NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins(2023)
Authors: Samal Bissenova, Rita Derua, Chantal Mathieu, Conny Gysemans, Lut Overbergh
- Neutrophils in autoimmunity: when the hero becomes the villain(2022)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
Pages: 128 - 140 - Net proteome and bioenergetic profile of PMA- and ionomycin-stimulated neutrophils point to metabolic alterations in neutrophils of people with longstanding type 1 diabetes(2022)
Authors: Samal Bissenova, Rita Derua, Chantal Mathieu
Pages: S208 - S209 - Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice(2021)
Authors: Samal Bissenova, Ylke Bruggeman, Aïsha Callebaut, Chantal Mathieu, Lut Overbergh
Pages: 516 - 528